| Jul 28 2023 |
DOJ Enters Into DPAs with Former Deerfield Traders and CMS Consultant |
ArentFox Schiff LLP |
| Jul 27 2023 |
CMS Proposes Changes to Medicare Provider Enrollment Rules |
Polsinelli PC |
| Jul 27 2023 |
Avoiding Antitrust Traps for the Unwary: Guardrails for Healthcare Transactions [Podcast] |
Nelson Mullins |
| Jul 27 2023 |
No Snipe Hunting: AIA Adherence Means No Interference (Proceedings) |
McDermott Will & Schulte LLP |
| Jul 27 2023 |
FTC and DOJ Take Key Actions with Antitrust Guidance Affecting Healthcare |
Dinsmore & Shohl LLP |
| Jul 27 2023 |
New Medicare Marketing Definition |
Squire Patton Boggs (US) LLP |
| Jul 27 2023 |
CMS Proposes Remedy for 340B-Acquired Drug Payment Policy for CY 2018-2022 |
Foley & Lardner LLP |
| Jul 27 2023 |
As COVID-19 Public Emergency Ends, So Do Vaccination Mandates |
Epstein Becker & Green, P.C. |
| Jul 27 2023 |
FTC and HHS Warn Hospitals and Telehealth Providers About Use of Tracking Technologies |
Robinson & Cole LLP |
| Jul 27 2023 |
Do You Have a College Student? Maintaining Decision-Making Rights During Unexpected Situations |
Goulston & Storrs |
| Jul 27 2023 |
FDA Maintains Focus on “Intended Use” for Software-Enabled Medical Devices |
Sheppard, Mullin, Richter & Hampton LLP |
| Jul 27 2023 |
5 Questions with Ben Handel: The Use of Algorithms in Healthcare |
Cornerstone Research |
| Jul 27 2023 |
Antitrust Enforcement Mid-Year 2023 Review |
Cadwalader, Wickersham & Taft LLP |
| Jul 27 2023 |
U.S. Executive Branch Update – July 27, 2023 |
Squire Patton Boggs (US) LLP |
| Jul 26 2023 |
FTC Announces Withdrawal of Healthcare Policy Statements |
Bradley Arant Boult Cummings LLP |
| Jul 26 2023 |
FTC and OCR Unite to Safeguard Hospital and Telehealth Data from Online Tracking Threats |
Proskauer Rose LLP |
| Jul 25 2023 |
FTC Joins DOJ In Withdrawing from Long-Standing Health Care Antitrust Policy Statements |
K&L Gates LLP |
| Jul 25 2023 |
OIG Issues Final Information Blocking Enforcement Rule and Highlights the Potential for Referrals to the FTC and FCA Liability |
Proskauer Rose LLP |
| Jul 25 2023 |
First Nonprescription Birth Control Pill Approved for Marketing by FDA: A Milestone for Reproductive Health |
Mintz |
| Jul 25 2023 |
HRSA Uninsured Program Covid-19 Services: OIG Audit Finds HRSA Paid for Claims that did not Comply with Federal Requirements |
Foley & Lardner LLP |
| Jul 25 2023 |
Legislative Responses to Recent Developments in Generative Artificial Intelligence |
K&L Gates LLP |
| Jul 25 2023 |
U.S. Executive Branch Update – July 24, 2023 |
Squire Patton Boggs (US) LLP |
| Jul 24 2023 |
Supreme Court Declines to Hear Case Regarding Gender Dysphoria’s Status Under the Americans with Disabilities Act |
Epstein Becker & Green, P.C. |
| Jul 24 2023 |
Regulators Send Warning Letter to Hospitals and Telehealth Providers About Tracking Technology Use |
Sheppard, Mullin, Richter & Hampton LLP |
| Jul 22 2023 |
Additional Withdrawals of Long-Standing Guidance and Newly Proposed Merger Guidelines |
Epstein Becker & Green, P.C. |
| Jul 21 2023 |
Cal/OSHA Standards Board Considers ETS for Respirable Crystalline Silica Exposure in Engineered Stone Fabrication Industry |
Ogletree, Deakins, Nash, Smoak & Stewart, P.C. |
| Jul 21 2023 |
Trending in Telehealth: July 11 – 17, 2023 |
McDermott Will & Schulte LLP |
| Jul 21 2023 |
MCDERMOTTPLUS CHECK-UP: JULY 21, 2023 |
McDermott Will & Schulte LLP |
| Jul 21 2023 |
Government Brings FCA Action Against Laboratory Companies |
ArentFox Schiff LLP |
| Jul 21 2023 |
Louisiana Legislature Passes Law Requiring Employers to Give Time Off for Genetic Testing and Cancer Screening |
Jackson Lewis P.C. |
| Jul 21 2023 |
NSW Supreme Court Considers Inherent Risk and Peer Professional Opinion in Bariatric Surgery Case Polsen v Harrison (NO. 8) |
K&L Gates LLP |
| Jul 21 2023 |
OCR and FTC Issue Joint Statement Warning Health Care Providers and App Developers About Use of Third Party Online Tracking Technologies |
Mintz |
| Jul 21 2023 |
HHS and FTC Send Joint Letter to 130 Hospital Systems, Telehealth Providers Re: Tracking Technologies |
Jackson Lewis P.C. |
| Jul 21 2023 |
Take Two: CMS’s Second Attempt to Streamline Breakthrough Device Coverage Limited to 5 Devices Per Year |
Epstein Becker & Green, P.C. |
| Jul 21 2023 |
Post-Dobbs Hospital Risk Assessment, Part 2: Impacts Beyond Abortion |
ArentFox Schiff LLP |
